facebooktwitterlinkedin
Health Resources Hub / Mental Health / Addiction

Yoga May Help Speed Recovery During Opioid Withdrawal

Investigators found yoga helped calm the nervous system, a key driver of withdrawal symptoms.

By

Lana Pine

Published on January 14, 2026

4 min read

Withdrawing from opioids is physically and emotionally challenging, even when medications like buprenorphine are used to ease symptoms. One reason withdrawal can be so difficult is that it disrupts the body’s autonomic nervous system (the system that controls heart rate, breathing, stress responses and relaxation). During withdrawal, the body often stays stuck in a heightened fight-or-flight state, which can increase anxiety, pain, sleep problems and the risk of relapse.

A new randomized clinical trial explored whether yoga, used alongside standard medication treatment, could help the body recover more quickly during opioid withdrawal. Results showed that adding yoga to standard treatment helped patients recover from opioid withdrawal nearly twice as fast.

“Yoga, encompassing physical postures, breathing techniques, meditation and relaxation, is uniquely positioned to address the need for accessible interventions that can be initiated even during acute withdrawal by directly enhancing parasympathetic tone and promoting physiological self-regulation,” wrote a team of investigators led by Suddala Goutham, MSc, of the Department of Integrative Medicine at the National Institute of Mental Health and Neurosciences in Bengaluru, India.

The study included 59 adult men with opioid use disorder who were hospitalized for mild to moderate withdrawal. All participants received buprenorphine, and about half also took part in 10 supervised, 45-minute yoga sessions over two weeks. These sessions included gentle postures, breathing exercises, relaxation techniques and guided meditation.

The findings were striking. Patients who practiced yoga stabilized from withdrawal much faster than those who received medication alone. On average, people in the yoga group reached withdrawal stabilization in about five days, compared with nine days in the control group. Overall, participants who did yoga were more than four times as likely to recover faster.

Investigators also measured heart rate variability, an objective marker of how well the autonomic nervous system is functioning. Higher variability generally reflects better balance between stress and relaxation. The yoga group showed significant improvements in these measures, suggesting their nervous systems were better able to shift out of stress mode and into recovery. Further analysis showed that increased parasympathetic (calming) activity explained nearly a quarter of yoga’s benefit on withdrawal recovery.

Beyond faster stabilization, yoga also improved symptoms that often make withdrawal harder to tolerate. Patients in the yoga group experienced greater reductions in anxiety, fell asleep faster (by about an hour on average) and reported less pain compared with those receiving medication alone.

Taken together, the results suggest that yoga may help treat opioid withdrawal not just by easing symptoms but by addressing underlying biological stress responses that medications don’t fully target.

Investigators noted several limitations of the study, including that it was conducted at a single site, lasted only a short time and included mostly male participants, which limits how broadly the results can be applied. While opioid misuse in the study setting primarily affects men, the team stresses the need for larger, multisite studies that intentionally include more women and diverse populations. Although most participants misused tapentadol, the biological stress responses seen during withdrawal are similar across opioids, suggesting yoga may offer benefits beyond this specific drug. Still, future studies are needed to confirm these findings in real-world settings, across different opioids, including fentanyl, and alongside other proven treatments.

“By targeting parasympathetic restoration, yoga may fill a critical therapeutic gap in standard opioid use disorder (OUD) care, supporting integration into withdrawal protocols as a neurobiologically informed intervention with potential economic benefits,” investigators concluded.